vs
MANNKIND CORP（MNKD）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
MANNKIND CORP的季度营收约是REGIS CORP的2.0倍（$112.0M vs $57.1M），REGIS CORP净利率更高（0.8% vs -14.2%，领先15.0%），MANNKIND CORP同比增速更快（45.8% vs 22.3%），REGIS CORP自由现金流更多（$891.0K vs $-10.0M），过去两年MANNKIND CORP的营收复合增速更高（30.0% vs 7.8%）
曼凯德公司是一家生物制药企业，成立于1991年2月，总部位于美国康涅狄格州丹伯里，专注于糖尿病、肺动脉高压等疾病治疗药物的研发、生产及商业化推广，致力于为相关患者提供创新的治疗方案。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
MNKD vs RGS — 直观对比
营收规模更大
MNKD
是对方的2.0倍
$57.1M
营收增速更快
MNKD
高出23.6%
22.3%
净利率更高
RGS
高出15.0%
-14.2%
自由现金流更多
RGS
多$10.8M
$-10.0M
两年增速更快
MNKD
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $112.0M | $57.1M |
| 净利润 | $-15.9M | $456.0K |
| 毛利率 | 87.6% | — |
| 营业利润率 | -6.9% | 10.8% |
| 净利率 | -14.2% | 0.8% |
| 营收同比 | 45.8% | 22.3% |
| 净利润同比 | -314.9% | -94.0% |
| 每股收益（稀释后） | $-0.05 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MNKDRGS
| Q4 25 | $112.0M | $57.1M | ||
| Q3 25 | $82.1M | $59.0M | ||
| Q2 25 | $76.5M | $60.4M | ||
| Q1 25 | $78.4M | $57.0M | ||
| Q4 24 | $76.8M | $46.7M | ||
| Q3 24 | $70.1M | $46.1M | ||
| Q2 24 | $72.4M | $49.4M | ||
| Q1 24 | $66.3M | $49.2M |
净利润MNKDRGS
| Q4 25 | $-15.9M | $456.0K | ||
| Q3 25 | $8.0M | $1.4M | ||
| Q2 25 | $668.0K | $116.5M | ||
| Q1 25 | $13.2M | $250.0K | ||
| Q4 24 | $7.4M | $7.6M | ||
| Q3 24 | $11.6M | $-853.0K | ||
| Q2 24 | $-2.0M | $91.2M | ||
| Q1 24 | $10.6M | $-2.3M |
毛利率MNKDRGS
| Q4 25 | 87.6% | — | ||
| Q3 25 | 94.5% | — | ||
| Q2 25 | 94.0% | — | ||
| Q1 25 | 95.2% | — | ||
| Q4 24 | 93.7% | — | ||
| Q3 24 | 95.4% | — | ||
| Q2 24 | 92.3% | — | ||
| Q1 24 | 94.2% | — |
营业利润率MNKDRGS
| Q4 25 | -6.9% | 10.8% | ||
| Q3 25 | 23.0% | 10.0% | ||
| Q2 25 | 6.9% | 12.1% | ||
| Q1 25 | 28.5% | 8.8% | ||
| Q4 24 | 34.5% | 11.8% | ||
| Q3 24 | 18.2% | 4.6% | ||
| Q2 24 | 22.9% | — | ||
| Q1 24 | 25.2% | 8.3% |
净利率MNKDRGS
| Q4 25 | -14.2% | 0.8% | ||
| Q3 25 | 9.7% | 2.3% | ||
| Q2 25 | 0.9% | 192.9% | ||
| Q1 25 | 16.8% | 0.4% | ||
| Q4 24 | 9.7% | 16.4% | ||
| Q3 24 | 16.5% | -1.9% | ||
| Q2 24 | -2.8% | 184.7% | ||
| Q1 24 | 16.0% | -4.7% |
每股收益（稀释后）MNKDRGS
| Q4 25 | $-0.05 | $0.16 | ||
| Q3 25 | $0.03 | $0.49 | ||
| Q2 25 | $0.00 | $43.67 | ||
| Q1 25 | $0.04 | $0.08 | ||
| Q4 24 | $0.03 | $2.71 | ||
| Q3 24 | $0.04 | $-0.36 | ||
| Q2 24 | $-0.01 | $38.40 | ||
| Q1 24 | $0.04 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $171.3M | $18.4M |
| 总债务越低越好 | $354.6M | $113.3M |
| 股东权益账面价值 | $-51.0M | $188.7M |
| 总资产 | $792.2M | $588.3M |
| 负债/权益比越低杠杆越低 | — | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资MNKDRGS
| Q4 25 | $171.3M | $18.4M | ||
| Q3 25 | $260.0M | $16.6M | ||
| Q2 25 | $179.0M | $17.0M | ||
| Q1 25 | $181.5M | $13.3M | ||
| Q4 24 | $197.3M | $10.2M | ||
| Q3 24 | $251.6M | $6.3M | ||
| Q2 24 | $247.8M | $10.1M | ||
| Q1 24 | $300.7M | $5.9M |
总债务MNKDRGS
| Q4 25 | $354.6M | $113.3M | ||
| Q3 25 | $109.7M | $111.3M | ||
| Q2 25 | $36.2M | $110.8M | ||
| Q1 25 | $36.1M | $112.0M | ||
| Q4 24 | $36.1M | $111.5M | ||
| Q3 24 | $227.9M | $95.2M | ||
| Q2 24 | $227.6M | $99.5M | ||
| Q1 24 | $264.1M | $179.7M |
股东权益MNKDRGS
| Q4 25 | $-51.0M | $188.7M | ||
| Q3 25 | $-44.6M | $187.6M | ||
| Q2 25 | $-55.0M | $185.6M | ||
| Q1 25 | $-58.6M | $68.6M | ||
| Q4 24 | $-78.8M | $66.7M | ||
| Q3 24 | $-209.9M | $56.4M | ||
| Q2 24 | $-225.8M | $56.8M | ||
| Q1 24 | $-230.0M | $-35.8M |
总资产MNKDRGS
| Q4 25 | $792.2M | $588.3M | ||
| Q3 25 | $494.6M | $592.1M | ||
| Q2 25 | $411.7M | $599.0M | ||
| Q1 25 | $410.1M | $511.2M | ||
| Q4 24 | $393.8M | $530.1M | ||
| Q3 24 | $464.2M | $508.9M | ||
| Q2 24 | $443.8M | $530.5M | ||
| Q1 24 | $480.9M | $543.7M |
负债/权益比MNKDRGS
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.67× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.75× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.0M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-10.0M | $891.0K |
| 自由现金流率自由现金流/营收 | -8.9% | 1.6% |
| 资本支出强度资本支出/营收 | 1.8% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $13.7M | $14.9M |
8季度趋势，按日历期对齐
经营现金流MNKDRGS
| Q4 25 | $-8.0M | $1.7M | ||
| Q3 25 | $23.6M | $2.3M | ||
| Q2 25 | $8.9M | $6.8M | ||
| Q1 25 | $-6.4M | $6.2M | ||
| Q4 24 | $22.6M | $2.1M | ||
| Q3 24 | $9.3M | $-1.3M | ||
| Q2 24 | $3.8M | $5.1M | ||
| Q1 24 | $6.7M | $-277.0K |
自由现金流MNKDRGS
| Q4 25 | $-10.0M | $891.0K | ||
| Q3 25 | $22.5M | $1.9M | ||
| Q2 25 | $7.8M | $6.2M | ||
| Q1 25 | $-6.7M | $5.9M | ||
| Q4 24 | $19.7M | $1.7M | ||
| Q3 24 | $7.9M | $-1.4M | ||
| Q2 24 | $861.0K | $5.1M | ||
| Q1 24 | $4.3M | $-326.0K |
自由现金流率MNKDRGS
| Q4 25 | -8.9% | 1.6% | ||
| Q3 25 | 27.4% | 3.2% | ||
| Q2 25 | 10.2% | 10.3% | ||
| Q1 25 | -8.6% | 10.3% | ||
| Q4 24 | 25.7% | 3.6% | ||
| Q3 24 | 11.3% | -3.0% | ||
| Q2 24 | 1.2% | 10.3% | ||
| Q1 24 | 6.5% | -0.7% |
资本支出强度MNKDRGS
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | 1.4% | 0.7% | ||
| Q2 25 | 1.5% | 0.9% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 3.8% | 0.9% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 4.1% | 0.0% | ||
| Q1 24 | 3.6% | 0.1% |
现金转化率MNKDRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | 2.96× | 1.68× | ||
| Q2 25 | 13.40× | 0.06× | ||
| Q1 25 | -0.48× | 24.80× | ||
| Q4 24 | 3.05× | 0.28× | ||
| Q3 24 | 0.81× | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | 0.63× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MNKD
| Products | $50.4M | 45% |
| Royalty | $33.6M | 30% |
| Afrezza | $22.9M | 20% |
| V Go | $4.3M | 4% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
